Have a personal or library account? Click to login

The key factors contributing to the risk, diagnosis and treatment of non-tuberculous mycobacterial opportunistic infections

Open Access
|Oct 2021

Figures & Tables

Figure 1

Clinical diseases caused by non-tuberculous mycobacteria. Common and less common isolated NTM species are listed in an alphabetical order [8, 9, 10].
Clinical diseases caused by non-tuberculous mycobacteria. Common and less common isolated NTM species are listed in an alphabetical order [8, 9, 10].

Figure 2

Predisposing factors for non-tuberculous mycobacterial diseases [47, 50].
Predisposing factors for non-tuberculous mycobacterial diseases [47, 50].

Figure 3

MALDI-TOF spectra of protein extracts of Mycobacterium spp. Expanded view of MALDI-TOF mass spectra representing Mycobacterium spp. from Polish Collection of Microorganisms (PCM): (A) M. farcinogenes PCM 2220, (B) M. kansasii PCM 2584, (C) M. smegmatis PCM 494, (D) M. peregrinum PCM 639, (E) M. phlei PCM 654, (F) M. smegmatis PCM 657. Colonies grown on Löwenstein-Jensen agar were incubated at 37°C for 72 h. Spectra were acquired using extraction protocol according to El Khéchine et al. [67].
MALDI-TOF spectra of protein extracts of Mycobacterium spp. Expanded view of MALDI-TOF mass spectra representing Mycobacterium spp. from Polish Collection of Microorganisms (PCM): (A) M. farcinogenes PCM 2220, (B) M. kansasii PCM 2584, (C) M. smegmatis PCM 494, (D) M. peregrinum PCM 639, (E) M. phlei PCM 654, (F) M. smegmatis PCM 657. Colonies grown on Löwenstein-Jensen agar were incubated at 37°C for 72 h. Spectra were acquired using extraction protocol according to El Khéchine et al. [67].

Methods used for identification of non-tuberculous mycobacterial species [57, 63, 76]

Culture-independentCulture-dependent
MethodLimitationMethodLimitation
HistologyCell granulomatosis indistinguishablePhenotypic methodsTime consuming, does not allow
from Tb-Biochemical testingidentification of the newly described
species
Smear microscopyNTM not distinguishable from MtbChemotaxonomical methodsNot available in all clinical laboratories
-HPLC of mycolic acids
Nucleic acid amplification testUsing for excluding MtbDirect probe hybridization assayLimited number of species
-Commercial NAAT
Real-time PCRLow sensitivity, limited range of speciesLine probe assayLimited number of species
– in-house methods -Commercial test
Serological testingCross-reactivity16S DNA sequencingLimited discriminatory power
Multigene sequencingExpensive, not available in clinical
-Whole genome sequencinglaboratories
Highly trained staff
MALDI-TOF MSDatabase content; quality of protein extracts

Sources of non-tuberculous mycobacteria [4, 12, 41, 42, 44, 47, 48]

Natural environment
Lakes, streams, rivers, ground water and seawater
Soil and dust from soil
Amoebae
Aquatic insects
Water plants and water distribution systems
Household/ Hospital environment
Plumbing systems
Tap water, shower heads, and faucets
Swimming pools, hot tubs, footbaths, hydrotherapy pools
Ice machines
Humidifiers
Dialysis centers
Heater-cooler units
Potting and garden soil
Aquarium water
Food products
Rainwater tanks and cooling towers
Indirect human-to-human transmission
Language: English
Page range: 696 - 710
Submitted on: Feb 4, 2021
Accepted on: May 17, 2021
Published on: Oct 30, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Anna Grzegorzewicz, Mariola Paściak, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.